rs28391521

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_003661.4(APOL1):​c.315-136A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.824 in 1,138,988 control chromosomes in the GnomAD database, including 388,049 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.86 ( 56192 hom., cov: 28)
Exomes 𝑓: 0.82 ( 331857 hom. )

Consequence

APOL1
NM_003661.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.76

Publications

3 publications found
Variant links:
Genes affected
APOL1 (HGNC:618): (apolipoprotein L1) This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
APOL1 Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 4, susceptibility to
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BP6
Variant 22-36265015-A-G is Benign according to our data. Variant chr22-36265015-A-G is described in ClinVar as [Benign]. Clinvar id is 1183411.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.944 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APOL1NM_003661.4 linkc.315-136A>G intron_variant Intron 5 of 5 ENST00000397278.8 NP_003652.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APOL1ENST00000397278.8 linkc.315-136A>G intron_variant Intron 5 of 5 1 NM_003661.4 ENSP00000380448.4 O14791-1

Frequencies

GnomAD3 genomes
AF:
0.857
AC:
130163
AN:
151826
Hom.:
56138
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.952
Gnomad AMI
AF:
0.796
Gnomad AMR
AF:
0.873
Gnomad ASJ
AF:
0.819
Gnomad EAS
AF:
0.844
Gnomad SAS
AF:
0.842
Gnomad FIN
AF:
0.844
Gnomad MID
AF:
0.823
Gnomad NFE
AF:
0.804
Gnomad OTH
AF:
0.835
GnomAD4 exome
AF:
0.819
AC:
808381
AN:
987044
Hom.:
331857
AF XY:
0.819
AC XY:
404829
AN XY:
494586
show subpopulations
African (AFR)
AF:
0.957
AC:
21127
AN:
22086
American (AMR)
AF:
0.893
AC:
19434
AN:
21758
Ashkenazi Jewish (ASJ)
AF:
0.832
AC:
14294
AN:
17176
East Asian (EAS)
AF:
0.843
AC:
28462
AN:
33754
South Asian (SAS)
AF:
0.834
AC:
48731
AN:
58398
European-Finnish (FIN)
AF:
0.843
AC:
38521
AN:
45670
Middle Eastern (MID)
AF:
0.772
AC:
2336
AN:
3024
European-Non Finnish (NFE)
AF:
0.808
AC:
599829
AN:
741990
Other (OTH)
AF:
0.825
AC:
35647
AN:
43188
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
6791
13582
20373
27164
33955
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12696
25392
38088
50784
63480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.857
AC:
130275
AN:
151944
Hom.:
56192
Cov.:
28
AF XY:
0.860
AC XY:
63897
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.952
AC:
39456
AN:
41448
American (AMR)
AF:
0.873
AC:
13342
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.819
AC:
2844
AN:
3472
East Asian (EAS)
AF:
0.844
AC:
4345
AN:
5150
South Asian (SAS)
AF:
0.842
AC:
4040
AN:
4800
European-Finnish (FIN)
AF:
0.844
AC:
8910
AN:
10562
Middle Eastern (MID)
AF:
0.823
AC:
242
AN:
294
European-Non Finnish (NFE)
AF:
0.804
AC:
54607
AN:
67922
Other (OTH)
AF:
0.836
AC:
1763
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
905
1810
2716
3621
4526
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
888
1776
2664
3552
4440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.902
Hom.:
12771
Bravo
AF:
0.865
Asia WGS
AF:
0.852
AC:
2961
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.1
DANN
Benign
0.59
PhyloP100
-2.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28391521; hg19: chr22-36661061; COSMIC: COSV59868406; COSMIC: COSV59868406; API